Pfizer (France)

Recent papers from Pfizer (France)

1. Current practices and access to cardiac bone scintigraphy for diagnosing transthyretin cardiac amyloidosis: results of a large national surveyEJNMMI Research · 2026
2. A plain language summary of the 7-year results from the CROWN study: lorlatinib compared with crizotinib in people with ALK-positive non-small cell lung cancerFuture Oncology · 2026
3. Time Course of Rimegepant Effect for Acute Treatment of Migraine in Adults Unsuitable for Triptans: Exploratory Endpoints from a Phase 4, Randomized, Double-Blind, Placebo-Controlled StudyNeurology and Therapy · 2026
4. Lyme Borreliosis Awareness, Risk Perception, and Willingness to Vaccinate in France: Where Do We Stand?Pathogens · 2026
5. Patient Preferences for the Treatment of Haemophilia A and B in FranceHaemophilia · 2026
6. Impact of Disease History on the Efficacy of Ritlecitinib in Patients With Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 StudyJID Innovations · 2026
7. Seasonal dynamics and burden of respiratory syncytial virus, influenza, and COVID-19 in Brazil: a national surveillance study (2019–2023)Journal of Global Health · 2026
8. Community-Level Patterns in Lyme Disease Incidence Among Medicare and Medicaid BeneficiariesInternational Journal of Environmental Research and Public Health · 2026
9. Dermatologists’ Perspectives and Real-World Assessment of Alopecia Areata Severity, Burden, and Healthcare Resource Utilization in Adults in the Kingdom of Saudi ArabiaDermatology and Therapy · 2026
10. Dermatologists’ Perspectives and Real-World Assessment of Alopecia Areata Severity, Burden, and Healthcare Resource Utilization in Adults in the United Arab EmiratesDermatology and Therapy · 2026
11. Differences in influenza and pneumococcal vaccination coverage according to chronic respiratory diseases during the COVID-19 pandemic in France in France: a nationwide cohort study using the French National Health Data SystemRespiratory Medicine and Research · 2026
12. Real-world feasibility of first-line palbociclib for hormone receptor-positive HER2-negative locally advanced/metastatic breast cancer in women aged 70 years and older – final results of the endocrine-sensitive cohort in the French prospective non-interventional PalomAGE studyThe Breast · 2026
13. Treatment Patterns and Direct Costs of Multiple Myeloma in Brazil: A Retrospective Cohort Analysis Using Real‐World DataPharmacoepidemiology and Drug Safety · 2026
14. Clinical validation of tissue and liquid companion diagnostics for BRAF V600E detection in non-small cell lung cancers from the PHAROS studyCancer Research Communications · 2026
15. Cost effectiveness and public health impact of PCV20 among adults in FranceBMC Public Health · 2026
16. Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in the 20-Valent Pneumococcal Conjugate Vaccine in the Adult Population in FranceOpen Forum Infectious Diseases · 2026
17. Prospective collection of bleeding rate and factor usage in participants with hemophilia A and B in a noninvestigational product studyResearch and Practice in Thrombosis and Haemostasis · 2026
18. Impact of hemophilia on social functioning: a qualitative descriptive study in BrazilBlood Global Hematology · 2026
19. A plain language summary of the BASIS study looking at people living with severe hemophilia A or B with inhibitors and being treated with marstacimabTherapeutic Advances in Hematology · 2026
20. The Clinical and Symptomatic Burden Among Older Adults with Respiratory Syncytial Virus: A Real-World Survey in Five European CountriesInfectious Diseases and Therapy · 2026